On the other hand, our data suggest that TGF-β-expressing Breg populations were prominent in patient blood, and both IHC/IF and scRNA-seq analyses in tumor lesions demonstrated the presence of a significant population of TGF-β+ B cells in the TME. This evidence concerns the gene TGFB1 and neoplasm.